GlassScriptPhysician profile
Michelle V Taylor
NPI 1093888539
$1,436.38
in general payments reported to CMS, 2019-2025
24 companies · $356 in 2025
The $356 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $282 · 2022: $250 · 2023: $353 · 2024: $196 · 2025: $356.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $905.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $904.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $254.19 | 2022-2025 | Trelegy Ellipta |
| Kerecis Limited | $197.30 | 2021-2024 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| W. L. Gore & Associates, INC. | $134.08 | 2021-2025 | Gore Excluder Thoracoabdominal Branch Endoprosthesis |
| Boston Scientific Corporation | $95.46 | 2021-2025 | Eluvia, Enroute Transcarotid Neuroprotection System, Ekosonic |
| Solventum Corporation | $91.42 | 2024-2025 | Prevena, V.A.C.Ulta |
| Kci USA, INC. | $90.25 | 2021-2023 | Prevena |
| Stryker Corporation | $72.58 | 2025 | Artix Mt |
| Terumo Medical Corporation | $56.25 | 2021-2024 | Azur Cx Detachable, Angio-Seal |
| Janssen Pharmaceuticals, INC | $51.24 | 2022-2023 | Xarelto |
| Silk Road Medical, INC. | $42.58 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Davol INC. | $36.78 | 2023 | Arista Ah Flexitip |
| Convatec INC. | $36.52 | 2025 | |
| Cardiovascular Systems INC. | $31.08 | 2022 | |
| Access Pro Medical, LLC | $30.29 | 2023 | Matriderm |
| Lemaitre Vascular, INC. | $26.62 | 2023 | Artegraft Vascular Graft |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $26.33 | 2021 | |
| Bioventus LLC | $25.51 | 2022 | |
| Smith+Nephew, INC. | $24.37 | 2021 | |
| United Therapeutics Corporation | $23.11 | 2022 | |
| Lantheus Medical Imaging, INC. | $21.13 | 2022 | |
| Angiodynamics, INC. | $18.52 | 2021 | |
| Kls-Martin L.P. | $18.34 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.62 | 2022 | |
| Bard Peripheral Vascular, INC. | $15.81 | 2024 | Rotarexs 6 F X 135 Cm |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Taylor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.